LUNG R&D to Revenue
Pulmonx Corp · R&D to Revenue
LUNG R&D to Revenue
Latest reported21.54%period ending
LUNG FY R&D/Revenue (34.95% → 21.54%)
Latest values, visible window
High-resolution chart · PNG
LUNG r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 21.5377% | |
| 20.9693% | |
| 26.3269% | |
| 28.6926% | |
| 26.9808% | |
| 22.7905% | |
| 18.5581% | |
| 34.948% |